In the United States, we typically don’t associate tattooing with medicine — these practices appear more intertwined in other countries.
When the Supreme Court decided Loper Bright Enterprises v. Raimondo in June 2024, health care fraud was not foremost on anyone’s mind.
President Trump’s recent executive order directing federal agencies to finalize the rescheduling of cannabis from Schedule I to Schedule III marks a watershed moment in American drug policy.
The United States Food and Drug Administration (FDA) has a unique funding structure among federal scientific and health agencies. The industries it regulates fund nearly half of its budget. The agency charges companies a user fee…
Social media, pharmaceutical pricing, neurotech, mental health, abortion, psychedelics, and GLP1s generated high interest on the Bill of Health blog this year.
Medical debt has become a fixture in our health care marketplace, with 41 percent of working-age Americans reportedly struggling to pay their medical bills.
Even though asthma takes an enormous toll on patients throughout the United States, many struggle to afford asthma medication.
The U.S. has the highest maternal mortality rate among developed nations. And yet, since 2020, a staggering 116 rural labor and delivery (L&D) wards in America have shuttered their doors, representing an 11 percent reduction in the overall number of…
In health law, we tend to speak about regulations and court rulings. But behind every case file, there is something more: a story, an emotion, and, above all, a person.
According to popular accounts, the U.S. Drug Enforcement Administration’s (DEA) scheduling of LSD and other psychedelics in 1968 shut down promising research for decades.
